Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

This publication has 42 references indexed in Scilit:

• Vanilloid VR₁receptor is involved in rimonabant‐induced neuroprotection
  British Journal of Pharmacology, 2006
• UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
  European Neuropsychopharmacology, 2006
• Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD40: Relevance to Parkinson's disease
  Journal of Neuroscience Research, 2005
• Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils
  British Journal of Pharmacology, 2005
• Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
  Neurobiology of Disease, 2005
• Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
  Cell and tissue research, 2004
• The therapeutic potential of the cannabinoids in neuroprotection
  Expert Opinion on Investigational Drugs, 2002
• Perinatal Δ9-Tetrahydrocannabinol Exposure Did Not Alter Dopamine Transporter and Tyrosine Hydroxylase mRNA Levels in Midbrain Dopaminergic Neurons of Adult Male and Female Rats
  Neurotoxicology and Teratology, 1998
• Scavenging Effects of Dopamine Agonists on Nitric Oxide Radicals
  Journal of Neurochemistry, 1996
• Pergolide can induce soluble Superoxide dismutase in rat striata
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992